Taysha Gene Therapies (NASDAQ:TSHA) Price Target Raised to $12.00 at Needham & Company LLC
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) had its target price lifted by Needham & Company LLC from $10.00 to $12.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price target indicates a potential upside of 163.16% from the [...]